
Stock·NASDAQ·Technology
Cirrus Logic Inc. (CRUS)
- Market cap
- $5.99B
- P/E
- 15.15
- Dividend yield
- No dividend
- Street target
- $160.00median of 5 analysts
- 52-week range
- $105.10 $180.42
CRUS stock today, November 11, 2026: price, news and analyst targets
As of November 10, 2026, Cirrus Logic Inc. (CRUS) trades at $120.17. Wall Street's median 12-month price target is $160.00 across 5 analysts, 33.1% above the price. CleaRank rates it Buy with a score of 64/100.
Cirrus Logic's stock is trading at $120.17, up 6.99% over the past week, but it remains 33.39% below its 52-week high of $180.42 and sits below its 200-day average of $138.42. The rebound has come as the stock recovered above its 50-day average of $114.66, yet the longer-term picture is still weak: the 1-year return is 1.20%, the 6-month return is -27.81%, and the stock fell 4.97% after its November 4, 2026 report despite an EPS beat. Analyst sentiment has cooled in October, with Barclays downgrading to Underweight and Keybanc moving to Equal-Weight, even as CleaRank's own score of 64/100 remains in its Buy band on valuation and profitability.
Earnings beats have not lifted the shares
Cirrus Logic reported adjusted EPS of $2.70 on November 4, 2026, against an analyst estimate of $2.42, a beat of 11.57%. The shares nonetheless fell 4.97% in the first session after the report. The pattern is not new: the company has beaten EPS estimates in all six reports on record, and four of those six beats were followed by a lower share price in the first session. Investors appear to be weighing something other than the headline EPS figure, though the reason for the sell-off is not clear from the reports themselves.
Analyst ratings have moved lower
Two rating changes in October stand out. Keybanc downgraded the stock to Equal-Weight from Overweight on October 15, 2026, and Barclays downgraded it to Underweight from Equal-Weight on October 21, 2026. Susquehanna kept its Positive rating on the same day as the Barclays move. Three months ago, three of five analysts rated the stock buy; today two of five do. The consensus is Hold, and the median 12-month target of $160.00 is still 33.1% above the price.
Valuation looks low against peers, but revenue is flat
The trailing P/E of 15.15 is at a discount to peers: it sits 56.8% below the sector median of 35.1, and the price-to-sales ratio of 2.93 is 61.4% below the sector median of 7.6. Return on equity of 19.54% is above the sector median of 13.4%, and debt-to-equity is 0.06.
Insider selling without open-market buying
Insiders sold $18.6M of stock over the last 18 months across 32 sales, and made no open-market purchases in that period. Insider sales are often planned in advance or made to cover tax on vesting shares, so they are a weaker signal than purchases would be. It is not known whether these particular sales were planned.
CleaRank score 64/100 (Buy). 11 of 18 checks pass: trend 1 of 4, momentum 3 of 3, valuation and quality 4 of 4, analysts 1 of 3, track record 2 of 4.
About Cirrus Logic
Cirrus Logic Inc. is a fabless semiconductor company that designs high-precision mixed-signal processing solutions for mobile and consumer electronics. Cirrus Logic’s product portfolio includes audio codecs, smart codecs, boosted amplifiers, haptic driver and sensing solutions, camera controllers, battery and power ICs, digital signal processors, and related software and algorithms. These components are used in smartphones, tablets, laptops, wearables, truly wireless headsets, AR/VR headsets, home theater systems, smart home devices, and automotive entertainment systems.
CRUS stock news
Barclays moves to Underweight
·Barclays
Barclays downgraded the stock to Underweight from Equal-Weight on October 21, 2026.
Keybanc cuts to Equal-Weight
·Keybanc
Keybanc downgraded the stock to Equal-Weight from Overweight on October 15, 2026, reducing the number of buy-rated analysts and adding to the pressure on the consensus.
Susquehanna keeps Positive view
·Susquehanna
Susquehanna kept its Positive rating on October 21, 2026, showing that at least one firm stayed constructive as other analysts cut their ratings.
EPS beat in November report
·Earnings report
Adjusted EPS of $2.70 beat the $2.42 estimate by 11.57% in the November 4, 2026 report, the sixth straight beat on record. Investors reacted negatively in the first session, so the beat is a catalyst that has not yet produced a lasting rally.
Keybanc and Stifel reaffirm in August
·Keybanc
Keybanc kept its Overweight rating and Stifel kept its Buy rating on August 6, 2026, while Barclays kept its Equal-Weight rating that day. These reaffirmations are the baseline the October downgrades moved away from.
CRUS price target 2026
The base case is a stock that keeps trading between its short-term averages and the 200-day average. The 50-day average at $114.66 has become the first floor, and the 200-day average at $138.42 is the first hurdle the stock must clear to repair its longer-term trend. Analysts' median 12-month target is $160.00, within a range of $95.00 to $170.00, but only two of five analysts rate the stock buy or strong buy. A move back above the 200-day average would support the bullish case; a break below $105.10, the 52-week low, would weaken it and would call the recent recovery into question.
Analyst targets and ratings
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 21, 2026 | Susquehanna | Maintains | Positive |
| Oct 21, 2026 | Barclays | Downgrade | Underweight |
| Oct 15, 2026 | Keybanc | Downgrade | Equal-Weight |
| Aug 6, 2026 | Keybanc | Maintains | Overweight |
| Aug 6, 2026 | Stifel | Maintains | Buy |
| Aug 6, 2026 | Barclays | Maintains | Equal-Weight |
CRUS support and resistance levels
Support sits first at the 50-day simple moving average of $114.66, followed by the 20-day exponential moving average at $113.79. The 52-week low of $105.10 is the deeper floor; a fall to it would take the stock back to the bottom of its yearly range. Resistance sits first at the 200-day simple moving average of $138.42, which the stock has not reclaimed. Above it is the 52-week high of $180.42, the level the stock would need to reach to erase the yearly decline.
| Level | What it is | Price | From the price |
|---|---|---|---|
| Resistance 2 | 52-week high | $180.42 | +50.1% |
| Resistance 1 | 200-day moving average | $138.42 | +15.2% |
| Price | November 10, 2026 | $120.17 | |
| Support 1 | 50-day moving average | $114.66 | -4.6% |
| Support 2 | 20-day exponential average | $113.79 | -5.3% |
| Support 3 | 52-week low | $105.10 | -12.5% |
Technical indicators
CRUS stock price and trading
CRUS share price
CRUS fundamentals and valuation
Key statistics
CRUS against the Technology sector
Price to earnings vs sector: CRUS trades at a notable discount to sector peers (-57% against the sector median P/E). Investors are paying less for each dollar of earnings than for the typical stock in the sector.
Return vs XLK: Since May 30, 2025, CRUS has gained 22.2% against a gain of 46.3% for XLK.
Performance against XLK
Revenue and earnings
Revenue growth: Revenue grew 5.3% in FY2026 to $2.0B, from $1.9B a year earlier.
Profit margin: The net margin was 20.7% in FY2026, up from 17.5% the year before.
Profitable: CRUS earned $414M in FY2026.
Earnings reality check
Earnings record: CRUS beat the analyst estimate in 6 of the last 6 quarters.
Market reaction: The stock fell in the first session after 4 of those 6 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Nov 4, 2026after close | $2.42 | $2.70 | +11.57% | -4.97% | - |
| Aug 5, 2026after close | $1.81 | $1.84 | +1.66% | -4.57% | -5.82% |
| May 6, 2026after close | $1.76 | $1.95 | +10.80% | +2.38% | -0.74% |
| Feb 3, 2026after close | $2.44 | $2.97 | +21.72% | +8.29% | +14.05% |
| Nov 4, 2025after close | $2.38 | $2.83 | +18.91% | -7.88% | -7.12% |
| Aug 5, 2025after close | $1.10 | $1.51 | +37.27% | -7.35% | +3.50% |
CRUS price history and drawdowns
Risk profile
Worst falls and recoveries
Growth of $10,000
Against the market: CRUS trailed the S&P 500 over this period: $24,360 against $39,967.
A $10,000 investment in CRUS in December 2016 would be worth about $24,360 today, compared with about $39,967 for the same investment in the S&P 500 benchmark with its dividends reinvested.
CRUS stock price prediction 2030
CRUS Stock Price Prediction 2030: Simulated Scenarios
CleaRank's simulation projects a price near $158 for CRUS by 2030 in the base case, from $120 today (1.3x over 4 years). The 10th-percentile path ends near $56.97. These are outcomes of a Monte Carlo simulation run on CRUS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $77.27 | $129 | $214 | |
| 2028 | $66.98 | $138 | $283 | |
| 2029 | $60.99 | $148 | $357 | |
| 2030 | $56.97 | $158 | $438 |
CRUS insider trading
CRUS insider trading
Month by month
Net insider selling: No insider bought CRUS shares on the open market in the last 18 months. Sales are often planned in advance or cover tax on vesting shares, so they say less than purchases would.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Oct 20, 2026 | Jeffrey W Baumgartner
Officer
|
Sell | 1.2K | $125.6K |
| Sep 21, 2026 | Jeffrey W Baumgartner
Officer
|
Sell | 1.2K | $138.8K |
| Aug 20, 2026 | Jeffrey W Baumgartner
Officer
|
Sell | 1.2K | $137.5K |
| Jul 29, 2026 | Alexander M Davern
Director
|
Option | 2.0K | $267.9K |
| Jul 29, 2026 | Alexander M Davern
Director
|
Grant | 2.0K | - |
| Jul 29, 2026 | Muhammad Raghib Hussain
Director
|
Grant | 2.0K | - |
| Jul 29, 2026 | Muhammad Raghib Hussain
Director
|
Option | 2.0K | $267.9K |
| Jul 29, 2026 | Duy-Loan T Le
Director
|
Grant | 2.0K | - |
| Jul 29, 2026 | Catherine P Lego
Director
|
Option | 2.0K | $267.9K |
| Jul 29, 2026 | Catherine P Lego
Director
|
Grant | 2.0K | - |
CRUS stock forecast: questions people ask
CRUS Forecast: Frequently Asked Questions
What is the CRUS stock forecast?
What is the CRUS price target?
Is CRUS a buy or sell today?
Why did CRUS fall after its latest earnings?
How profitable is Cirrus Logic?
How these figures are computed, and where the data comes from: CleaRank methodology.